Carregant...
Combination Use of Tegafur and Apatinib as First-Line Therapy in Treatment of Advanced Gastric Cancer: A Single-Blinded Randomized Study
OBJECTIVE: To investigate the efficacy and safety of the combination use of tegafur and apatinib as a first-line therapy strategy in advanced gastric cancer (GC). METHODS: The present study included a total of 62 advanced GC patients. The patients were randomized into the combined group (treated wit...
Guardat en:
| Publicat a: | Gastroenterol Res Pract |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7165347/ https://ncbi.nlm.nih.gov/pubmed/32328095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3232950 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|